ARIPIPRAZOLE        SUPPORTING DATA 
Supporting data
Supported by GSK.
(c) 2004 Excerpta Medica
All rights reserved.
Disclaimer
print this page
 Aripiprazole versus haloperidol in mania
Authors: Bourin et al. 
Title: Aripiprazole vs. haloperidol for maintained treatment effect in acute mania
Reference: European Neuropsychopharmacology. The Journal of the European College of Neuropsychopharmacology 2003;13(Suppl 4):S333.
Purpose: To compare the maintenance of treatment in aripiprazole- and haloperidol-treated patients with bipolar disorder over 12 weeks of treatment of an acute manic episode.
Study design: Randomized, double-blinded trial.
Follow up: 12 weeks. 
Patients: 347 patients.
Treatment: Aripiprazole 15 mg/day or haloperidol 10 mg/day. 
Results: For the maintenance of an acute manic episode at 12 weeks, aripiprazole treatment led to significantly higher response rates and improved tolerability compared with haloperidol.

 
  
home help sitemap acronyms help sitemap home